Web Analytics

3 Latest Announced Rounds

  • $90,000,000
    Series A

    2 Investors

    Software Development
    Oct 7th, 2025
  • $1,311,818
    Pre-Seed

    1 Investors

    Renewable Energy Semiconductor Manufacturing
    Oct 7th, 2025
  • $97,716,710
    Series A

    2 Investors

    Biotechnology
    Oct 7th, 2025
$1,088.68M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Orakl Oncology

start up
France - Paris, Île-de-France
  • 04/10/2023
  • Unknown
  • $3,147,000

Orakl leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster.


Related People

Fanny JaulinFounder

Fanny Jaulin France - Greater Paris Metropolitan Region

My research goals are two-fold: to study the biology of live primary cancer specimens to build relevant knowledge and to implement cell biology approaches in the clinic to patient benefits.
To serve these ambitious objectives, my lab develops cell biology expertise, organoid technology and leads collaborative multidisciplinary programs. Together, we articulate a continuum in biomedical research, from fundamental questions to clinical applications.